story of the week
Methylation Predicts Outcome in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
J. Clin. Oncol 2016 Nov 21;[EPub Ahead of Print], K Visvanathan, MS Fackler, Z Zhang, ZA Lopez-Bujanda, SC Jeter, LJ Sokoll, E Garrett-Mayer, LM Cope, CB Umbricht, DM Euhus, A Forero, AM Storniolo, R Nanda, NU Lin, LA Carey, JN Ingle, S Sukumar, AC WolffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.